This podcast is aimed at healthcare professionals, produced and funded by UCB.
This episode welcomes Dr John Ingram (HS Consultant Dermatologist at Cardiff University) to share an overview of what HS is, its presentation in patients, epidemiology and global prevalence.
Speaker disclosures:
Dr Barry McGrath and Dr John Ingram have received consulting fees, research or institutional support and educational grants from UCB.
Barry McGrath, PhD, has received consultancy/advisory board disease-related honoraria from Novartis and UCB.
Dr John Ingram receives a stipend as Editor-in-Chief of the British Journal of Dermatology and an authorship honorarium from UpToDate. He is a consultant for AbbVie, Boehringer Ingelheim, ChemoCentryx, Citryll, Novartis, and UCB, and has served on advisory boards for Insmed, Kymera Therapeutics, and Viela Bio. He is a co-copyright holder of HiSQOL, Investigator Global Assessment, and Patient Global Assessment instruments for HS. His department receives income from copyright of the Dermatology Life Quality Instrument (DLQI) and related instruments.
© UCB Biopharma SRL, 2023. All rights reserved.
Date of preparation: December 2023
IE-DA-2300159
","author_name":"UCB Biopharma"}